(Q38479473)

3 September 2017

Occurrence of colon ischemia in relation to irritable bowel syndrome (English)

1 reference

3 September 2017

4

Anuli N Ajene

1 reference

3 September 2017

J Alexander Cole

1

1 reference

3 September 2017

Suzanne F Cook

2

1 reference

3 September 2017

Bruce E Sands

3

1 reference

3 September 2017

David P Miller

5

1 reference

3 September 2017

Alexander M Walker

6

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

The American Journal of Gastroenterology

3 September 2017

1 reference

3 September 2017

99

1 reference

3 September 2017

3

1 reference

3 September 2017

486-491

1 reference

Constipation, diarrhea, and irritable bowel syndrome

3 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

Irritable bowel syndrome in general practice: prevalence, characteristics, and referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

The irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04097.X

10.1111/J.1572-0241.2004.04097.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference